BetterLife Pharma Inc C.BETR

Alternate Symbol(s): BETRF

Healthcare

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.

CSE:BETR - Post by User

BetterLife Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by rixpixon Mar 08, 2024 1:09pm

147 Views

Post# 35923111

Ok, Trying 1 more time to buy 250 thousand shares

I just entered another 2 orders to buy 250K shares @ 7.5 cents even though I prefer to buy at the ask when the SP reaches my buy price.I put it in, good for a couple of days with RBC.

If someone wants to sell or reduce their holdings feel free to fill the orders.

GLTA

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario